Researchers explore the power of podcasts in fighting infectious disease misinformation

With legacy media cutting staff in the face of unprecedented financial challenges and critical science and health information scattered among unfamiliar digital platforms, how can people keep up with medical issues that might affect them?

In PhIII data, Eli Lilly’s Retevmo meets primary endpoint of improving progression-free survival

Eli Lilly’s Retevmo to treat advanced or metastatic rearranged during transfection (RET)-mutant medullary thyroid cancer (MTC) showed promising results at improving progression-free survival compared to

August 24, 2023

AMG-305 by Amgen for Breast Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 8, 2023

Study identifies 80 genes linked to increased risk of breast cancer

Breast cancer is the most common malignancy among Western women, with up to 10% of cases attributed to genetic variants.

November 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.